𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders

✍ Scribed by Lucienne Michaux; Cristina Mecucci; Michel Stul; Iwona Wlodarska; Jesus Maria Hernandez; Peter Meeus; Jean-Louis Michaux; Jean-Marie Scheiff; Henri Noël; Andries Lodwagie; Arnold Criel; Marc Boogaerts; Angeline Van Orshoven; Jean-Jacques Cassiman; Herman Van den Berghe


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
695 KB
Volume
15
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Translocation t( 14; I9)(q32;q 13) is a rare but recurrent abnormatiy in chronic lymphocytic leukemia and small cell lymphoma.

It has been associated with rearrangements of the BCU gene, which is located at the breakpoint on chromosome 19 and is juxtaposed to the immunoglobutin heavy chain tocus on chromosome 14 as a result of the translocation. This results in transcriptional up-regulation of the BCU gene, which encodes a transcription coactivator, an I-KB protein, probably contributing to disease progression. We found, among 4,487 cytogenetic analyses of Iymphoproliferative disorders. six cases with a t( 14; I9)(q32;q 19, five of which showed the classical t( 14; 19)(q32;q 13) and one of which showed a three-way translocation t(7; 19; I4)(q2 I ;q I 3;q32). The 14; I9 translocation never occurred as a single abnormatitr; additional aberrations included trisomy I 2 and several structural abnormalities. The cytogenetic examination was supplemented by molecular analysis using available probes for the BCU locus (pat .4P and pa5B) in I, t 50 of the 4,487 patients. Rearrangements of Kl3 could be detected in five cases, all of which had the classical t( L4; 19). In the case with t(7; 19; 14). the suspected BCU involvement could only be confirmed using long-range restriction mapping, indicating that, with the usually available BCU probes, rearrangements of this locus may be missed. Genes Chromosom Concer 15t38-47 (1996). 0


📜 SIMILAR VOLUMES


Translocation t(11; 14)(q 13;q32) in chr
✍ Dr. V. Brito-Babapulie; J. Ellis; E. Matutes; D. Oscier; T. Khokhar; K. MacLenna 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 713 KB

The translocation t( I I ; I4)(q I3;q32) has been described in a spectrum of B-lymphoproliferative diseases and involves a putative oncogene, BCLI, which maps t o chromosome band I lq13. Recent evidence indicates that this abnormality may delineate particular subtypes of lymphoma, such as intermedia

t(14;19)(q32;q13): A recurrent transloca
✍ Hazel M. Robinson; Kerry E. Taylor; G. Reza Jalali; Kan Luk Cheung; Christine J. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 746 KB

The recurrent t(14;19)(q32;q13) translocation associated with chronic B-cell lymphoproliferative disorders, such as atypical chronic lymphocytic leukemia, results in the juxtaposition of the IGH@ and BCL3 genes and subsequent overexpression of BCL3. We report six patients with B-cell precursor acute

Correlation between losses of IGH or its
✍ Luba Trakhtenbrot; Izhar Hardan; Maya Koren-Michowitz; Shirley Oren; Galina Ysho 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB

## Abstract Multiple myeloma (MM) is a malignancy of the plasma cells (PCs) characterized by a wide variety of genetic and chromosomal abnormalities. In recent years, major attention was drawn to the significance of chromosomal aberrations involving chromosome arm 13q and the __IGH__ region on chro

The B cell antigen receptor in atypical
✍ Carmen D. Schweighofer; Yang O. Huh; Rajyalakshmi Luthra; Rachel L. Sargent; Rhe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 356 KB

## Abstract The t(14;19)(q32;q13) is a recurrent chromosomal translocation reported in a variety of B‐cell leukemias and lymphomas, including chronic lymphocytic leukemia (CLL). CLL cases associated with t(14;19) often have atypical morphologic and immunophenotypic features and unmutated immunoglob

Cyclin D1/PRAD1/BCL-1 alternative transc
✍ Yoshitaka Hosokawa; Tatsuroh Joh; Yumiko Maeda; Andrew Arnold; Masao Seto 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 66 KB 👁 1 views

The cyclin-D1/PRAD1 oncogene, a key regulator of the G 1 -phase progression of the cell cycle, has been identified as the long-sought BCL-1 oncogene in B-cell malignancies with t(11;14)(q13;q32) translocation. A novel alternative spliced cyclin-D1 transcript, called transcript[b], has been identifie